STEMLINE THERAPEUTICS INC — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/517af7c4-652b-461c-a88c-e3d1bbb01055/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-76.8M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-034154 |
| FY 2018 | $-328.2M | 2003-08-08 – 2019-03-31 | evidence 0001104659-19-028623 |
| FY 2017 | $-234.2M | 2003-08-01 – 2018-03-31 | evidence 0001104659-18-032190 |
| FY 2016 | $-38.3M | 2016-01-01 – 2016-12-31 | evidence 0001104659-18-018361 |
| FY 2015 | $-37.2M | 2015-01-01 – 2015-12-31 | evidence 0001104659-18-018361 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
STEMLINE THERAPEUTICS INC — all facts · Revenue · Operating Income